<DOC>
	<DOC>NCT01148329</DOC>
	<brief_summary>The goal of the PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post- Approval Surveillance Study is to evaluate real world clinical outcomes data for the PROMUS™ Element™ Coronary Stent System in unselected patients in routine clinical practice.</brief_summary>
	<brief_title>PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>According to Instructions For Use Contraindications according to Instructions for Use</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Coronary stenting</keyword>
	<keyword>Drug-eluting stent</keyword>
	<keyword>Post-market surveillance study</keyword>
	<keyword>Promus Element stent</keyword>
</DOC>